Streetbeat News

Regulatory

DKNG

DraftKings has announced plans to launch an online sportsbook in Maine through a partnership with the Passamaquoddy Tribe. The deal is subject to regulatory approval.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 9:24 pm

NVAX

Novavax has received approval from the European Union (EU) for its updated COVID-19 vaccine. The company is now working with EU member states to distribute the vaccine to those who have requested doses through the advance purchase agreement.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 9:08 pm

CLLS

Cellectis has presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:56 pm

NVS

The FDA has approved Novartis' Cosentyx for the treatment of moderate to severe Hidradenitis Suppurativa in adults. This approval could potentially increase Novartis' market share in the pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:55 pm

AURA

Aura Biosciences Inc. (NASDAQ:AURA) announced that updated data from the Phase 2 trial evaluating the safety and efficacy of its first virus-like drug conjugate (VDC) product candidate, bel-sar, for the first-line treatment of adult patients with early-stage choroidal melanoma will be presented at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting. The meeting will be held from November 3-6, 2023, in San Francisco.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:44 pm

TX

Ternium (TX) anticipates a sequential decrease in Q4 shipments in Argentina due to seasonality and government-imposed restrictions on the importation of inputs required for production by the company and its value chain.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:32 pm

TX

Ternium (TX) expects Q4 adjusted EBITDA to decrease compared to Q3, with lower adjusted EBITDA margin partially offset by slightly higher steel shipments. The company anticipates a sequential decrease in steel revenue per ton in Q4, reflecting lower realized prices in Mexico and Brazil. In Mexico, steel consumption is expected to remain strong, while in Brazil, shipments are expected to remain relatively stable. In Argentina, the company anticipates a sequential decrease in Q4 shipments due to seasonality and government-imposed restrictions.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:31 pm

CBRG

CBRGU

CBRGW

Chain Bridge I (NASDAQ:CBRGU, CBRG, CBRGW) has announced that it will redeem all of its outstanding Class A ordinary shares at a per-share price of approximately $10.80, effective as of the close of business on November 15, 2023. The decision comes as the company will not be able to consummate an initial business combination within the required time period. The company will cease all operations, except those required to wind up the business, and expects that the Nasdaq Stock Market will file a Form 25 with the U.S. Securities and Exchange Commission to delist its securities.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:01 pm

LIFW

MSP Recovery, Inc. (NASDAQ:LIFW) announced that it is now in compliance with all applicable Nasdaq listing standards, allowing its Class A common stock to continue to be listed and traded on the exchange. The company has rectified its previously disclosed bid price deficiencies. The stock has been trending higher after hitting an all-time low last week, following news that CEO John Hasan Ruiz bought 467,290 shares.

Portfolio Pulse from Ryan Gustafson

October 31, 2023 | 7:49 pm

CRSP

VRTX

A Stat News reporter has tweeted about a productive discussion at the FDA advisory committee meeting, focusing on the benefits of treatment for patients with Sickle Cell Disease (SCD) versus the theoretical risk of off-target editing. The companies mentioned are Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics (CRSP).

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:33 pm